Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2007 1
2008 2
2009 4
2010 4
2011 2
2012 5
2013 4
2014 4
2015 4
2016 6
2017 4
2018 13
2019 9
2020 9
2021 21
2022 10
2023 6
2024 8
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, Kerr K, Wang C, Ciuleanu TE, Saylors GB, Tanaka F, Ito H, Chen KN, Liberman M, Vokes EE, Taube JM, Dorange C, Cai J, Fiore J, Jarkowski A, Balli D, Sausen M, Pandya D, Calvet CY, Girard N; CheckMate 816 Investigators. Forde PM, et al. N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11. N Engl J Med. 2022. PMID: 35403841 Free PMC article. Clinical Trial.
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer.
Forde PM, Spicer JD, Provencio M, Mitsudomi T, Awad MM, Wang C, Lu S, Felip E, Swanson SJ, Brahmer JR, Kerr K, Taube JM, Ciuleanu TE, Tanaka F, Saylors GB, Chen KN, Ito H, Liberman M, Martin C, Broderick S, Wang L, Cai J, Duong Q, Meadows-Shropshire S, Fiore J, Bhatia S, Girard N; CheckMate 816 Investigators. Forde PM, et al. N Engl J Med. 2025 Aug 21;393(8):741-752. doi: 10.1056/NEJMoa2502931. Epub 2025 Jun 2. N Engl J Med. 2025. PMID: 40454642 Clinical Trial.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Mitsudomi T, Ito H, Okada M, Sugawara S, Shio Y, Tomii K, Okami J, Sakakura N, Kubota K, Takamochi K, Atagi S, Tsuboi M, Oizumi S, Ikeda N, Ohde Y, Ntambwe I, Mahmood J, Cai J, Tanaka F. Mitsudomi T, et al. Among authors: sakakura n. Cancer Sci. 2024 Feb;115(2):540-554. doi: 10.1111/cas.16030. Epub 2023 Dec 14. Cancer Sci. 2024. PMID: 38098261 Free PMC article. Clinical Trial.
Design variations in vertical muscle-sparing thoracotomy.
Sakakura N, Mizuno T, Arimura T, Kuroda H, Sakao Y. Sakakura N, et al. J Thorac Dis. 2018 Aug;10(8):5115-5119. doi: 10.21037/jtd.2018.07.100. J Thorac Dis. 2018. PMID: 30233887 Free PMC article. No abstract available.
The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study.
Miyoshi T, Aokage K, Watanabe SI, Ito H, Sakakura N, Mun M, Yamashita M, Ohde Y, Aoki T, Nishio W, Taguri M, Tsuboi M. Miyoshi T, et al. Among authors: sakakura n. Jpn J Clin Oncol. 2024 Nov 2;54(11):1185-1193. doi: 10.1093/jjco/hyae073. Jpn J Clin Oncol. 2024. PMID: 39255996 Free PMC article.
A prospective multi-institutional study to verify the non-inferiority of postoperative pain in robot-assisted thoracic surgery in comparison with video-assisted thoracoscopic surgery for lung cancer: The Japanese RATS interest group 01 (J-RATSIG 01).
Kawaguchi K, Ogura T, Kaneda S, Watanabe T, Soh J, Hashimoto K, Sakakura N, Okazaki M, Mori S, Hashimoto M, Fukumoto K, Miyajima M, Yoshida S, Moriyama S, Tamaru S, Takao M. Kawaguchi K, et al. Among authors: sakakura n. Lung Cancer. 2024 Oct;196:107961. doi: 10.1016/j.lungcan.2024.107961. Epub 2024 Sep 21. Lung Cancer. 2024. PMID: 39340899 Free article.
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies.
Akamatsu H, Nishikawa T, Takeda Y, Misumi T, Aoki T, Shoda H, Yamashita M, Sakakura N, Daga H, Sugawara S, Okishio K, Kenmotsu H, Yamamoto N, Tada H, Tsuboi M, Mitsudomi T. Akamatsu H, et al. Among authors: sakakura n. Lung Cancer. 2025 Mar;201:108437. doi: 10.1016/j.lungcan.2025.108437. Epub 2025 Feb 6. Lung Cancer. 2025. PMID: 39938189 Free article. Clinical Trial.
Smoking behavior-related genetic variants and lung cancer risk in Japanese: an assessment by mediation analysis.
Yamamoto S, Koyanagi YN, Iwashita Y, Shinozaki T, Fujiwara Y, Sakakura N, Hara M, Nishida Y, Otonari J, Ikezaki H, Tanoue S, Koriyama C, Kasugai Y, Oze I, Koyama T, Tomida S, Michihata N, Nakamura Y, Suzuki S, Nakagawa-Senda H, Nagayoshi M, Kubo Y, Kato Y, Wakai K, Watanabe T, Ishizu M, Takashima N, Kadota A, Momozawa Y, Nakatochi M, Tamura T, Niimi A, Ito H, Matsuo K. Yamamoto S, et al. Among authors: sakakura n. Carcinogenesis. 2025 Apr 3;46(2):bgaf011. doi: 10.1093/carcin/bgaf011. Carcinogenesis. 2025. PMID: 40059777
109 results